| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1319580 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SPRED2 mRNA | CTD | PMID:22079256 |
| 17beta-estradiol | decreases expression | ISO | RGD:1309304 | 6480464 | Estradiol results in decreased expression of SPRED2 mRNA | CTD | PMID:20068009 |
| 17beta-estradiol | decreases expression | ISO | RGD:1319580 | 6480464 | Estradiol results in decreased expression of SPRED2 mRNA | CTD | PMID:19167446 |
| 17beta-estradiol | increases expression | ISO | RGD:1319580 | 6480464 | Estradiol results in increased expression of SPRED2 mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPRED2 mRNA | CTD | PMID:21570461 |
| 2-methylcholine | affects expression | ISO | RGD:1319580 | 6480464 | beta-methylcholine affects the expression of SPRED2 mRNA | CTD | PMID:21179406 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of SPRED2 mRNA | CTD | PMID:20713471 |
| aflatoxin B1 | affects expression | ISO | RGD:1319580 | 6480464 | Aflatoxin B1 affects the expression of SPRED2 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1309304 | 6480464 | Tretinoin results in increased expression of SPRED2 mRNA | CTD | PMID:20488242 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of SPRED2 mRNA | CTD | PMID:19770486 |
| bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of SPRED2 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SPRED2 mRNA] | CTD | PMID:19850644 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPRED2 gene | CTD | PMID:20938992 |
| coumestrol | decreases expression | ISO | RGD:1319580 | 6480464 | Coumestrol results in decreased expression of SPRED2 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1319580 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPRED2 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | affects expression | ISO | RGD:1319580 | 6480464 | Asbestos, Crocidolite affects the expression of SPRED2 mRNA | CTD | PMID:17331233 |
| cyclosporin A | increases expression | ISO | RGD:1319580 | 6480464 | Cyclosporine results in increased expression of SPRED2 mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SPRED2 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of SPRED2 mRNA | CTD | PMID:15171707 |
| divanadium pentaoxide | affects expression | ISO | RGD:1319580 | 6480464 | vanadium pentoxide affects the expression of SPRED2 mRNA | CTD | PMID:17459161 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPRED2 gene | CTD | PMID:20938992 |
| formaldehyde | decreases expression | ISO | RGD:1319580 | 6480464 | Formaldehyde results in decreased expression of SPRED2 mRNA | CTD | PMID:20655997 |
| isotretinoin | increases expression | ISO | RGD:1319580 | 6480464 | Isotretinoin results in increased expression of SPRED2 mRNA | CTD | PMID:20436886 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPRED2 gene | CTD | PMID:20938992 |
| lead(0) | decreases expression | ISO | RGD:1319580 | 6480464 | Lead results in decreased expression of SPRED2 mRNA | CTD | PMID:19921347 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SPRED2 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1319580 | 6480464 | Acetaminophen results in decreased expression of SPRED2 mRNA | CTD | PMID:21420995 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of SPRED2 mRNA | CTD | PMID:17950772 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1319580 | 6480464 | tert-Butylhydroperoxide results in increased expression of SPRED2 mRNA | CTD | PMID:15336504 |
| zinc atom | multiple interactions | ISO | RGD:1319580 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SPRED2 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1319580 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SPRED2 mRNA | CTD | PMID:18593933 |